NCT04251962View on ClinicalTrials.gov

Role of Opioids in Epidural Solutions

PHASE4CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

March 2, 2022

Study Completion Date

March 2, 2022

Conditions
Postoperative Pain
Interventions
DRUG

Bupivacaine

epidural solution containing bupivacaine 0.1% in normal saline

DRUG

Fentanyl

Epidural solution containing fentanyl 3 mcg/ml (in addition to bupivacaine) in normal saline

Trial Locations (1)

Unknown

Division of Anesthesia, Pain and Critical Care, Tel-Aviv Sourasky Medical Center, Tel Aviv

All Listed Sponsors
collaborator

Israel Society of Anesthesiologists

UNKNOWN

lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV

NCT04251962 - Role of Opioids in Epidural Solutions | Biotech Hunter | Biotech Hunter